XML 26 R11.htm IDEA: XBRL DOCUMENT
v3.22.2.2

REVENUES | 9 Months Ended
--- | ---
Sep. 30, 2022
REVENUES |
REVENUES | NOTE 4 – REVENUES ​ The following table summarizes the Company’s disaggregation of revenues: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Three Months Ended September 30, | ​ | Nine Months Ended September 30,
(U.S. dollars in thousands) |  | 2022 |  | 2021 | ​ | 2022 |  | 2021
Pfizer | ​ | $ | 4,541 | ​ | $ | 1,135 | ​ | $ | 11,279 | ​ | $ | 7,883
Brazil | ​ | $ | 1,708 | ​ | $ | 3,200 | ​ | $ | 7,162 | ​ | $ | 4,188
Chiesi | ​ | $ | 2,563 | ​ | $ | 171 | ​ | $ | 2,781 | ​ | $ | 189
Total revenues from selling goods | ​ | $ | 8,812 | ​ | $ | 4,506 | ​ | $ | 21,222 | ​ | $ | 12,260
Revenues from license and R&D services | ​ | $ | 5,371 | ​ | $ | 7,548 | ​ | $ | 17,799 | ​ | $ | 17,541
​

X
- Definition The entire disclosure pertaining to revenue. + References No definition available. + Details
Name: | plx_RevenueDisclosureTextBlock
Namespace Prefix: | plx_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueRecognitionAndDeferredRevenueAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration